[Congressional Record Volume 162, Number 89 (Tuesday, June 7, 2016)]
[Senate]
[Pages S3560-S3561]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 4484. Mrs. ERNST (for herself and Mr. Johnson) submitted an 
amendment intended to be proposed by her to the bill S. 2943, to 
authorize appropriations for fiscal year 2017 for military activities 
of the Department of Defense, for military construction, and for 
defense activities of the Department of Energy, to prescribe military 
personnel strengths for such fiscal year, and for other purposes; which 
was ordered to lie on the table; as follows:

       At the end of subtitle I of title X, add the following:

     SEC. 1097. BIODEFENSE STRATEGY.

       (a) In General.--Title V of the Homeland Security Act of 
     2002 (6 U.S.C. 311 et seq.) is amended by adding at the end 
     the following:

     ``SEC. 527. NATIONAL BIODEFENSE STRATEGY.

       ``(a) Definitions.--In this section--
       ``(1) the term `biodefense' means any involvement in 
     mitigating the risks of major biological incidents and public 
     health emergencies to the United States, including with 
     respect to--
       ``(A) threat awareness;
       ``(B) prevention and protection;
       ``(C) surveillance and detection;
       ``(D) response and recovery; and
       ``(E) attribution of an intentional biological incident;
       ``(2) the term `Council' means the Biodefense Coordination 
     Council established under subsection (b);
       ``(3) the term `Federal biodefense enterprise' means the 
     programs, projects, activities, and resources across the 
     Federal Government that are involved in biodefense; and
       ``(4) the term `Strategy' means the National Biodefense 
     Strategy required to be established under subsection (b)(5).
       ``(b) Biodefense Coordination Council.--
       ``(1) Establishment.--The President shall establish a 
     Biodefense Coordination Council, which shall be comprised of, 
     at a minimum--
       ``(A) the Secretary of Health and Human Services;
       ``(B) the Secretary of Agriculture;
       ``(C) the Secretary of Defense;
       ``(D) the Secretary;
       ``(E) the Secretary of State;
       ``(F) the Director of National Intelligence; and
       ``(G) the Administrator of the Environmental Protection 
     Agency.
       ``(2) Duties.--The Council shall--
       ``(A) provide the expertise necessary to develop the 
     Strategy; and
       ``(B) in coordination with the Office of Management and 
     Budget, review, prioritize, and align necessary biodefense 
     activities and spending across the Federal Government, in a 
     manner consistent with the Strategy.
       ``(3) Rotating chair.--During the 4-year period beginning 
     on the date on which the Council is established, and each 4-
     year period thereafter, each of the 4 Secretaries described 
     in subparagraphs (A) through (D) of paragraph (1) shall serve 
     as the chairperson for the Council for 1 year. The first 
     chairperson of the Council shall be the Secretary of Health 
     and Human Services.
       ``(4) President's annual budget.--The recommendations of 
     the Council shall inform the budget submitted by the 
     President under section 1105 of title 31, United States Code, 
     with respect to biodefense activities.
       ``(5) Strategy.--The President shall develop a National 
     Biodefense Strategy to direct and align the inter-
     governmental and multi-disciplinary efforts of the Federal 
     Government towards an effective and continuously improving 
     biodefense enterprise, including threat awareness, prevention 
     and protection, surveillance and detection, and

[[Page S3561]]

     response and recovery to major biological incidents.
       ``(c) Coordination.--
       ``(1) Council.--In developing the Strategy, the President 
     shall utilize the Council.
       ``(2) Other agencies.--In developing the Strategy, the 
     President may utilize--
       ``(A) the Secretary of Commerce;
       ``(B) the Attorney General; and
       ``(C) any other Federal department, agency, or interagency 
     body the President determines appropriate, including the 
     Public Health Emergency Medical Countermeasures Enterprise.
       ``(3) Other entities.--The President may receive input on 
     elements of the Strategy from private sector biodefense 
     entities and State, local, tribal, and territorial 
     governments.
       ``(4) Academic institutions.--The President may receive 
     input on elements of the Strategy from academic institutions.
       ``(d) Coordination With Existing Strategies.--The Strategy 
     shall serve as a comprehensive guide for United States 
     biodefense that directs and harmonizes all other strategies 
     or plans established or maintained by a Federal department or 
     agency with respect to biodefense.
       ``(e) Contents.--
       ``(1) Requirements.--The Strategy shall include, at a 
     minimum--
       ``(A) a comprehensive description of the entities and 
     positions of leadership with responsibility, authority, and 
     accountability for implementing, overseeing, and coordinating 
     Federal biodefense activities described in subsection (b)(5), 
     including a description of how such entities coordinate on 
     each aspect of biodefense;
       ``(B) 5-year goals, priorities, and metrics to improve and 
     strengthen the ability of the Federal Government to prevent, 
     detect, respond to, and recover from a major biological 
     incident;
       ``(C) short- and long-term research and development 
     projects or initiatives planned to improve biodefense 
     capability; and
       ``(D) recommendations for legislative action needed to 
     expedite progression toward the goals identified in the 
     Strategy.
       ``(2) Considerations.--In developing the Strategy, the 
     President may consider--
       ``(A) the trade-offs made between differing goals and 
     requirements, due to constraints in expected assets and 
     resources over the time period of such goals and 
     requirements; and
       ``(B) any other analysis the President determines 
     appropriate.
       ``(3) Analysis.--The Strategy shall include an appendix, 
     which shall contain--
       ``(A) a review of current and previous collaborative 
     efforts between the Armed Forces and the civilian sector of 
     the Federal Government on biodefense activities and 
     coordination;
       ``(B) a detailed analysis of the--
       ``(i) relevant recommendations issued by external 
     biodefense review panels or commissions, and the extent to 
     which the recommendations have been considered and 
     implemented by Federal departments and agencies;
       ``(ii) lessons learned from the response of the Federal 
     Government to public health emergencies occurring within the 
     5 years preceding the submission of the strategy;
       ``(iii) risks associated with major biological incidents;
       ``(iv) resources and capabilities needed to address 
     identified risks; and
       ``(v) resource and capability gaps in the Federal 
     biodefense enterprise, including gaps in--

       ``(I) each category of biodefense activity described in 
     subsection (a)(1);
       ``(II) identification and research of emerging biological 
     threats;
       ``(III) programs, projects, and activities in effect before 
     the date of enactment of this section;
       ``(IV) strategies and implementation plans related to 
     biodefense activities in effect before the date of enactment 
     of this section;
       ``(V) the ability to reallocate Federal resources to 
     address risks posed by emerging biological threats; and
       ``(VI) meeting the needs of vulnerable populations during 
     the response to and recovery from a public health emergency; 
     and

       ``(C) prioritization and allocation of investment across 
     the Federal biodefense enterprise.
       ``(f) Deadline.--Not later than 24 months after the date of 
     enactment of this section and in accordance with subsection 
     (k), the President shall submit the Strategy to the Committee 
     on Homeland Security and Governmental Affairs of the Senate 
     and the Committee on Homeland Security of the House of 
     Representatives.
       ``(g) Status Updates.--Not later than 180 days after the 
     date of enactment of this section, and every 180 days 
     thereafter until the date on which the Strategy is submitted 
     to the congressional committees described in subsection (f), 
     the President shall submit to such congressional committees 
     an update on the status of the Strategy.
       ``(h) Requirement.--In accordance with subsection (k), the 
     Strategy shall be made available on a public Internet 
     website.
       ``(i) Five-Year Update.--Beginning 5 years after the date 
     on which the Strategy is submitted to the congressional 
     committees described in subsection (f), and not less 
     frequently than every 5 years thereafter, the President shall 
     update the Strategy.
       ``(j) Annual Biodefense Expenditures Report.--
       ``(1) In general.--Not later than 30 days after the date on 
     which the President submits a budget to Congress under 
     section 1105 of title 31, United States Code, the President 
     shall submit to the appropriate congressional committees a 
     report detailing the total amount of expenditures on 
     biodefense activities by all Federal departments and agencies 
     and how the expenditures relate to the goals and priorities 
     required under subsection (e)(1)(B).
       ``(2) Requirement.--The first report submitted under 
     paragraph (1) shall provide historical context by detailing 
     the total amount of expenditures on biodefense for the 3 
     preceding fiscal years, in addition to the fiscal year 
     requirements for the fiscal year covered by the report.
       ``(k) Classified Annex.--To the fullest extent possible, 
     any reports required to be made publicly available under this 
     section shall be unclassified, but may include classified 
     annexes that shall be submitted concurrently to the 
     congressional homeland security committees.''.
       (b) Table of Contents.--The table of contents in section 
     1(b) of the Homeland Security Act of 2002 (6 U.S.C. 101 note) 
     is amended by inserting after the item relating to section 
     526 the following:

``Sec. 527. National Biodefense Strategy.''.
                                 ______